Less lab monitoring for methotrexate users may be safe, study suggests
NCT ID NCT07512401
First seen Apr 09, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study looked at over 2,400 people with rheumatic diseases who were taking methotrexate. Researchers compared those who had fewer lab tests to those who had standard monitoring to see if it was safe. The goal was to find out if less frequent blood work could still protect against serious side effects like liver damage or severe blood problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATIC DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.